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ABSTRACT 
CARING FOR THE PEDIATRIC NEUROFIBROMATOSIS 
TYPE-1 PATIENT:  IMPROVING NURSING KNOWLEDGE 
THROUGH AN INNOVATIVE EDUCATIONAL TOOL 
Standardized nursing education can help equip nurses with appropriate 
skills needed to care for certain patient populations.  Pediatric neurofibromatosis 
type-1 (NF1) patients have unique health needs, and often seek care at institutions 
where no NF1 training has been provided.  The purpose of this project was to 
explore existing nursing NF1 knowledge and knowledge perception in a pediatric 
oncology infusion center within a large bay area children’s hospital, a location 
where nurses have varied NF1 education and have recently been asked to care for 
this population.  Malcolm Knowles’ adult learning theory was used to design an 
NF1 educational tool for nurses.  The educational tool serves as a standardized 
reference from which nurses can familiarize themselves with the genetic nature of 
NF1, the clinical needs of the disorder, and the NF1 nursing role.  A pre- and post-
test survey was used to measure nursing knowledge and nursing knowledge 
perception, which was administered before and after the educational tool.  
Findings from this research suggest that the NF1 education tool is effective in 
improving nursing knowledge and knowledge perceptions about the complex care 
needed for NF1 patients.  While fulfilling the American Nurses Association 
genetic and genomic nursing competency requirements, this educational tool can 
be used to standardize NF1 nursing education in hopes to enhance nursing practice 
and ultimately improve NF1 patient outcomes. 
Samantha Ingerick 
May 2019 
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CHAPTER 1: INTRODUCTION 
 According to the National Institute of Health (NIH), neurofibromatosis 
type-1 (NF1) is an autosomal dominant disorder that affects 1 in 3,000 people 
worldwide (NIH, 2016).  It is the most common of the three types of 
neurofibromatosis, with type-2 (NF2) affecting 1 in 40,000 people and 
schwannomatosis affecting less than 1 in 40,000 people  (NIH, 2016).  NF1 can be 
inherited from a parent or can result from a spontaneous gene mutation (NIH, 
2016), and is caused by a mutation in the NF1 gene that is responsible for making 
the protein called neurofibromin (NIH, 2018).  The NF1 gene is located along the 
long (q) arm of chromosome 17 at position 11.2 (NIH, 2018), and acts as a 
negative regulator along the Ras signal transduction pathway (National Center for 
Biotechnology Information, 2018).  Abnormal neurofibromin production can lead 
to uncontrolled cellular activity along nerves, and ultimately form tumors under 
the skin surface, near the spinal cord, or along nerves located elsewhere in the 
body (NIH, 2018).    
NF1 is most commonly characterized by other associated conditions as 
well.  These include skin discolorations (café-au-lait spots and freckling of the 
axilla or groin), neurofibromas (benign growths underneath the skin), softening of 
bones, cognitive conditions and learning disabilities, Lisch nodules of the eyes, 
optic gliomas, and hypertension (Children’s Tumor Foundation, 2016).  The 
number of conditions a patient presents, and the severity of each condition, can 
vary between patients.  Because the NF1 gene is so large (60 exons), and because 
it has one of the highest rates of spontaneous mutations in the human genome, a 
large array of mutations can lead to the NF1 phenotype and thus the variety in 
phenotypic presentation (Boyd, Korf, & Theo, 2009).  The Children’s Tumor 
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Foundation (CTF) states that sixty percent of NF1 cases present with mild NF1 
manifestations (CTF, 2016), while 15% of NF1 patients have symptoms that are 
debilitating (NIH, 2016).  The NIH Consensus Development Program states that 
two or more of the following must present in order for a clinical NF1 diagnosis to 
be made: six or more café-au-lait macules over 5mm in size (pre-pubertal) or over 
15mm (post-pubertal), two or more neurofibromas or one plexiform neurofibroma, 
freckling of inguinal or axillary regions, optic glioma, two or more Lisch nodules, 
osseous lesion, or a first-degree relative with an NF1 diagnosis (NIH, 1987). 
Because of the wide variety of NF1 clinical presentations, treatment for 
NF1 can vary.  For patients who develop tumors or neurofibromas, surgical 
resections may be needed.  Optic gliomas often require ophthalmological 
assessments, surgery, radiation, or chemotherapy, while osseous lesions, 
pseudoarthrosis, or scoliosis may require orthopedic interventions (NIH, 2016).  In 
addition, varying degrees of cognitive functioning, processing speeds and attention 
or hyperactivity impairment can present.  Fifty percent of children with NF1 have 
learning challenges, poor social skills and difficulty forming friendships, all 
supporting the need for neuro-psychological evaluations and school needs 
assessments (CTF, 2016).  The complex medical needs of NF1 patients often 
require that several medical specialists be involved.  It is common for NF1 patients 
to be cared for by neurologists, dermatologists, cardiologists, geneticists, 
ophthalmologists, orthopedists, psychologists, oncologists, and school educators 
(CTF, 2016).  Nurses play key roles in the interdisciplinary NF1 care team 
including symptom management, prevention of complications, ensuring family 
centered care and education (Sampson, Thompson, & Wall Parilo, 2019).  While 
many nurses that care for pediatric NF1 patients and other genetic disorders are 
familiar with managing these complex needs, they sometimes lack experience or 
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have no formal educational training.  As Camak (2016) demonstrated, practicing 
nurses lack genomic literacy, knowledge, and skills resulting in inadequate ability 
to meet the needs of patients and families facing genetic disorders.  In 2018, 
Calzone, Jenkins, Culp, and Badzek found that of the 3,880,000 nurses in the U.S., 
most have had no genomic education (Calzone et al., 2018).   
Background 
With the publication of the Human Genome Project in April 2004, accurate 
gene sequences for each human chromosome were generated (National Human 
Genome Research Institute, 2016).  The project continues to launch subsequent 
discoveries about second-generation sequencing technologies that help advance 
the genomics field (Hood & Rowen, 2013).  Molecular medicine and genome 
research have since produced new information about genes involved in inherited 
disorders, genetic diseases and overall human health (Lessick & Anderson, 2000). 
 Now, after nearly two decades of genetic health advancement, there is the 
challenge of maintaining a competent workforce that can adequately translate 
these genomic discoveries into practice (Calzone et al., 2018).  Genomic 
information continues to transition into the clinical setting at quick rates, creating 
an urgency for medical professionals to receive genetic disorder education and 
provide competent care (Calzone et al., 2018).  Nurses are included in this group 
of health professionals who have a responsibility to be knowledgeable about 
genetic practices and to incorporate scientific advancement.  
The Genetic/Genomic Nursing Competency Initiative (GGNCI) was 
formed in 2004 from collaboration between the National Human Genome 
Research Institute and the National Cancer Institute (Genomic Nursing State of the 
Science Advisory Panel, 2013).  This group prioritized efforts to create a 
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genomics/genetics nursing competency strategic implementation plan.  The plan 
aimed to recognize that genetic nursing knowledge can impact patient care during 
risk assessments and discussions surrounding treatment decisions (Genomic 
Nursing State of the Science Advisory Panel, 2013).  This partnership, in 
collaboration with the American Nurses Association (ANA) produced a document 
titled The Essentials of Genetic and Genomic Nursing:  Competencies, Curricula 
Guidelines, and Outcome Indicators published in 2006, and later revised in 2008.  
This document aimed to reflect the minimal amount of genomic and genetic 
competencies expected from every nurse (ANA, 2009).  It was funded by the NIH, 
the National Human Genome Research Institute, the Office of Rare Disease, and 
the ANA (Lewis, Calzone, & Jenkins, 2006).  This publication was agreed upon 
by a consensus of 47 endorsing organizations including two schools of nursing and 
members of the Nursing Organization Alliance (Lewis et al., 2006).   
The document provides definitions of basic genetic and genomic 
terminology, professional nursing responsibilities with regards to genetic health, 
and expected outcomes for each competency.  It includes implementation 
strategies that outline the basic nursing educational requirements needed so that 
graduating nurses could deliver adequate genomic and genetic care (ANA, 2016).  
These guidelines were intended to apply to all registered nurses regardless of 
academic preparation, practice setting, role or specialty and aim to prepare the 
nursing workforce to deliver competent, genetic and genomic focused nursing care 
(Lewis et al., 2006).  This document has since been considered the gold standard 
for practicing nurses regarding genetic and genomic care (ANA, 2016).   
Also in 2008, the American Association of Colleges of Nursing (AACN) 
published an updated version of the Essentials of Baccalaureate Education for 
Professional Nursing Practice that outlined curricular elements and frameworks 
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used as guidelines for nursing educational programs around the U.S. (AACN, 
2008).  Understanding that nursing has potential to greatly impact healthcare 
delivery to patients, the AACN created 9 curriculum outcomes expected of 
baccalaureate nursing graduates that emphasize patient-centered care, evidence-
based practice, quality improvement, genetics and genomics, cultural sensitivity, 
professionalism, and other skills (AACN, 2008; Connors and Schorn, 2018).  In 
2011 the AACN acknowledged a subsequent report from the ANA and 
International Society of Nurses in Genetics (ISONG) titled Essential Genetic and 
Genomic Competencies for Nurses with Graduate Degrees (AACN, 2011).  This 
builds on the original 2009 consensus panel document while incorporating genetic 
advances and genetic competency guidelines for nurses with higher level degrees 
and leadership roles.  In addition to these institutions, other organizations have put 
forth efforts to standardize genomic and genetic nursing education (see Appendix 
E). 
Despite these many organizations attempting to regulate the amount of 
genetic-related education received by nursing graduates, a gap in genomic 
knowledge continues to exist amongst registered nurses today.  This could be the 
result of many reasons.  Calzone et al., (2018) explain that the complexity of 
genomic concepts, the ability of nursing academic institutions to change curricula, 
and the lack of state boards requiring genetic competencies as part of licensure 
may all play a part in the sluggish integration of this skill into the nursing culture. 
 The National Council of State Boards of Nursing (NCSBN) Test Plan for 2019 
claims to devote 6-12% of NCLEX Test Plan questions to the health promotion 
and maintenance category, which is divided into 9 subcategories.  One of these 
subcategories contains questions related to genetic screening, history, or risk 
assessment (NCSBN, 2018).  While it is difficult to determine the exact number of 
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test questions pertaining to genetic or genomic content, it is likely to be a small 
percentage of the exam.   
Transforming these genetic advances into current nursing practice can also 
be challenging for nurses (Camak, 2016).  With recent NF1 genetic discoveries 
emerging, nurses are asked to maintain a sufficient grasp of core scientific NF1 
concepts (Camak, 2016).  Considering the prevalence and complexity of NF1, it is 
likely that nurses will encounter patients with NF1 at some point throughout their 
careers (Julian, Edwards, DeCrane, & Hingtgen, 2014).  Those nurses with a 
generalized sense of current NF1 education may be better equipped to identify 
children with NF1, obtain a family history, conduct pertinent physical and 
development assessments, and provide the family with basic genetic information 
and psychosocial support (Lessick & Anderson, 2000).  A nurse who understands 
the pros and cons of NF1 genetic testing may be able to serve as an advocate for 
the patient, discuss screening or treatment choices, and contextualize any potential 
risks (Camak, 2016).  Genomic knowledge gaps can lower the effectiveness of 
utilizing genomic information during health care decision-making.  This can affect 
patient safety and outcomes of care (Calzone et al., 2018).   In response to these 
gaps, efforts have been made to educate professionals about NF1 and the clinical 
skill set needed to provide optimal care.   
The CTF is a national nonprofit foundation that was founded in 1978 to 
help find treatments for NF1 (CTF, 2016).  The CTF created the 
Neurofibromatosis Clinic Network (NFCN) in 2007 to help standardize NF1 care 
and integrate research into clinical practice within the U.S.  Currently 50 NF 
clinics within the U.S. are registered as specialty care clinics for this population 
and are dedicated to providing comprehensive medical care to those with NF, 
fostering patient education, promoting support and enrollment for NF1 clinical 
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trials, and updating the national NF patient registry (CTF, 2016).  The 
Neurofibromatosis Network is another non-profit 501(c)(3) organization based in 
Illinois that hopes to share resources, research, and improvements in clinical care 
in attempt to find a cure for neurofibromatosis and optimize patient outcomes 
(Neurofibromatosis Network, 2018).  Neurofibromatosis Inc. California is also a 
non-profit, volunteer organization located throughout California that was founded 
in 2004.  It is composed of individuals and families affected by NF1, and provides 
educational forums, family support groups, and resources for healthcare 
professionals and patients (Neurofibromatosis California, n.d.).  These 
organizations share common goals dedicated to advancing NF1 research, to 
educating others about NF1, and strive to supporting patients and families living 
with this disorder.  
Role of the NF1 Nurse 
When providing medical supervision to a child with NF1, the nurse or care 
coordinator plays a unique role.  Because of the various NF1 phenotypes, different 
NF1 patients may need to be monitored in various medical departments.  For 
example, some NF1 patients may be followed by genetics physicians and nurses, 
while other NF1 patients may be seen in the neurology or dermatology 
department.  The nurses in each of these departments all share the responsibility of 
providing competent care outlined by the ANA and the AACN to emphasize 
health promotion, prevention, caring, screening, and relationships (Munroe & 
Loerzel, 2016).   
Since the Scope and Standards for Clinical Genetics Nursing Practice was 
published in 1998 by the ANA and the International Society of Nurses in Genetics, 
genetics has been recognized as a nursing specialty (Montgomery, et al., 2017).  
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Learning outcomes were revised after the Human Genome Project was completed, 
and the ANA published the Essentials of Genetic and Genomic Nursing: 
 Competencies, Curricular Guidelines, and Outcome Indicators in 2009.  From 
these documents emerged preliminary descriptions of the nursing role when caring 
for patients with genetic disorders, and they specifically outlined genetic-related 
nursing skills expected of all nursing school graduates in the U.S. (Montgomery et 
al., 2017).  The nursing competencies listed in the ANA documents are divided 
into two categories: professional responsibilities and professional practice.  
Professional responsibilities include recognizing one’s attitudes related to genomic 
science that may affect client care, or advocating for the rights of all clients for 
autonomous, and informed genetic-related decision-making and voluntary action. 
 Similarly, professional practice includes the ability to elicit a 3-generation family 
history, developing a plan of care that incorporates genetic assessment 
information, identifying patients who may benefit from specific genomic 
information or services, and providing patients with knowledge of genetic-related 
risk factors or disease prevention practices (ANA, 2008).   
Since the development of these guidelines, the expectations of nurses 
caring for patients with genetic conditions have not changed.  The nursing 
workforce is expected to utilize a genetic pedigree while developing care plans, 
deliver patient education, and even provide some genetic counseling, referrals, or 
psychosocial health assessments (Camak, 2016).  With regards to the NF1 
population, nurses have the task of familiarizing themselves with NF1 so as to 
provide the patient and family comfort.  Barke, Coad, & Harcourt (2016) 
conducted a qualitative study in England that explored parents’ experiences of 
caring for a child with NF1.  Parents described feeling frustrated and angry 
because health professionals had not heard of NF1, or misunderstood it.  Results 
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from this study highlighted the value that parents place on up-to-date NF1 
information, access to health care professionals with NF1 knowledge, and on the 
importance of general public NF1 awareness.  It is important that the NF1 nurse 
addresses psychosocial needs of patients and families to provide them with 
comfort and reassurance. The nurse or care coordinator role includes providing 
proficient genetic and genomic care, but also involves translating NF1 knowledge 
into competent and confident nursing care so that families feel supported.   
Significance 
The birth incidence of NF1 is one in 1,900 to 2,800 cases worldwide.  The 
diagnostic prevalence, however, is higher (one in 4,150 to 4,950) because of the 
cases that are discovered later in early childhood, adulthood, or even at time of 
death (Evans, et al., 2017).  When looking at 20 year olds with NF1, a 
retrospective review study found that only 54% of them met criteria at age 1, 97% 
of them met criteria at age 8, and 100% met criteria by age 20 (Boyd, Korf, & 
Theos, 2009).  About 50% of NF1 cases result from spontaneous mutations and 
50% are inherited from a parent (Rasmussen & Friedman, 2000).  California is no 
exception to this prevalence, and with 1,938,153 people in Santa Clara County 
alone, any level-1 pediatric trauma  children’s hospital in that area would be 
expected to encounter patients who require NF1 care (US Census Bureau, 2017). 
One particular children’s hospital in the California bay area has recently 
joined the NFCN and become active within the CTF group to enhance the 
pediatric NF1 care within the Bay Area of Northern California.  Nurses within the 
pediatric oncology infusion center (a department within the larger hospital)  are 
now being asked to care for NF1 patients.  While the pediatric oncology nurses 
most likely had prior exposure to the pediatric NF1 population, their NF1 
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knowledge, education, and experiences are unknown and varied.  In preparation 
for transitioning the pediatric NF1 patients to the infusion center, an opportunity 
presented to examine the existing NF1 knowledge and nursing NF1 knowledge 
perceptions of these nurses.  Further investigation looked into the existence of a 
standardized nursing NF1 educational tool that could educate infusion center 
nurses should they be unfamiliar.  A novel NF1 educational PowerPoint tool was 
thus created and examined to determine its effectiveness in improving nursing 
NF1 knowledge and knowledge perception.  
Problem Statement 
There currently exists no standardized educational tool shown to improve 
nursing knowledge and nursing knowledge perceptions of pediatric NF1 care 
despite regulatory genetic and genomic educational requirements of the AACN 
and the ANA (AACN, 2008; ANA, 2008). 
Purpose of the project 
The purpose of this project was to create an effective educational tool 
(PowerPoint) for nurses to help improve nursing knowledge and nursing 
knowledge perceptions of pediatric NF1 care.  By measuring nursing knowledge 
of pediatric NF1 care before and after using this educational tool, the tool’s 
effectiveness could be determined.  In attempt to follow the AACN nursing 
educational guidelines and equip nurses with the academic background to provide 
safe and appropriate care for all patients with genomic and genetic conditions 
(AACN, 2008), the NF1 educational tool was made to help meet these goals.  The 
intentions of this tool also incorporated the mission of the CTF, which is to drive 
research, expand knowledge, and advance care for the NF community (CTF, 
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2016).  In doing so, this project aimed to benefit nurses’ NF1 education and 
ultimately improve NF1 patient outcomes.  
 
   
CHAPTER 2: LITERATURE REVIEW 
Existing Evidence 
To date, a standardized nursing NF1 educational tool that teaches the 
essential genetics and genomics curriculum requirements stated in the AACN does 
not exist (AACN, 2008).  While literature devotes attention to educational tools, 
websites, curricula guidelines and simulations pertaining to unspecified genetic 
disorders (ANA, 2008), none of these are specific to NF1 patients.  Knowing that 
NF1 patients require unique care that incorporates medical, psychosocial, and 
academic needs, there is an apparent void of standardized learning tools intended 
to help medical professionals learn about NF1.  Comprehensive literature searches 
using the full-text database Nursing and Allied Health search engine provided by 
the Henry Madden Library at University of California, Fresno State offered 
several peer-reviewed articles that highlight the importance of nursing genomic 
and genetic knowledge and competence.  While the literature suggests a 
disconnect between the expectations of nursing genetic competencies and the 
actual skill level portrayed in the nursing workforce, there seems to be no 
suggestion of a nurse-specific tool that could help resolve this disconnect.  The 
following literature review examines current publications that highlight the 
existing evidence surrounding nursing genetic competency and proficiency, as 
well as the lack of literature pertaining specifically to pediatric NF1 nursing 
knowledge. 
Camak (2016) conducted an extensive literature review looking at 20 
journal submissions from 2008 to 2015 relating to the incorporation of genetics 
into nursing practice.  Databases used included CINAHL, PubMED, American 
Association of Colleges of Nursing, NCHPEG, International Society of Genetic 
 13 13 
Nurses and ProQuest Nursing.  Of the 20 articles retrieved, 6 were research 
articles, 4 were published documents, and 10 were informational articles.  
Camak’s results found a consistent trend indicating that nurses lack genetic 
competency.  The author quotes Anderson et al. (2015), “despite a large and ever 
growing field of genomics knowledge, the profession of nursing has not yet 
incorporated core competencies for genomics into annual RN competency 
assessment and evaluation.”  Results suggest that barriers to integrating genetic 
content into nursing practice include poor understanding of its relevance, lack of 
state boards requirements for nurses to grasp this training prior to licensure, and 
limitations that prevent nurses from interpreting scientific genetic information and 
applying it to patient care.   
To help determine if nurses were utilizing elements of the AACN’s 
Essential Nursing Competencies and Curricula Guidelines in Genetics and 
Genomics (Essentials) in daily practice, Thompson and Brooks (2011) conducted 
a cross-sectional survey study.  The 17-question survey was sent to 200 nurses 
recruited from a convenience sample of conference attendees.  The survey 
included questions regarding nursing curriculum content, continuing education, 
nursing certification, and involvement in genetic/genomics research. The survey 
had a 24% response rate (n=47), and of those respondents only 36% had read the 
Essentials document.  Thompson and Brooks’ (2011) results suggest that content 
from the Essentials had not been reviewed by nurses other than those actively 
involved in genetic research or genetic continuing education, and that most 
respondents claimed that their school of nursing did not fully meet the Essentials 
competencies.  While this study had a small sample size and skewed results 
considering its subjects were recruited from a conference and may be 
academically focused, it concludes that most nurses did not have sufficient 
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knowledge regarding genetics and were not familiar with the competencies in the 
AACN Essentials document.  
Calzone, et al.(2018) were interested in exploring the effectiveness of a 
year-long program aimed at improving nursing ability to translate genomic 
information into clinical practice.  This longitudinal study took place from 2012 
and 2013 at 23 hospitals: a control group (2 hospitals) and an intervention group 
(21 hospitals representing 14 states).  Routine nursing education was offered 
monthly at the intervention hospitals only.  The Genetics and Genomics Nursing 
Practice Survey (GGNPS) was administered to nurses pre-intervention and post-
intervention (n=8,150 RNs).  Results indicate that intermittent nursing educational 
interventions such as genomic awareness campaigns, and personal genomic 
competency endorsement can increase nurses’ adherence to guidelines when 
integrating genomics into nursing practice. It also found the long intervention (1 
year) design improved genomic competency in the participating nurses, and that 
having a leadership involvement increased the likelihood that nurses would engage 
in learning to apply genomic information to bedside practice. 
Munroe and Loerzel (2016) created a pre-test/post-test survey study using a 
convenience sample of 120 baccalaureate nursing students at a nursing school in 
Florida (n=120).  The surveys were administered before and after a semester in 
which they would receive heavy genetics academic content. The Genomic Nursing 
Concept Inventory (GNCI) involved 31 multiple choice questions covering topics 
such as Human Genome Project, mutations, inheritance patterns, genomic health 
care applications, and attitudes about using genetic information in practice. 
 Results indicated a significant relationship (r=0.22, P=.02) between 
knowledgeable students and positive attitudes about their ability to use that 
knowledge.  Knowledge gains were seen between the pre-test and post-test, with a 
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difference of only 5% however.  Most students felt responsible for knowing the 
material covered in the course, but did not feel ready to practice this material with 
clinical patients.  This study suggests that students need more exposure to genetic 
conditions, possibly through re-evaluation of nursing curricula that can leave 
students feeling more confident in genomic care.  
 
Draucker, Nutakki, Varni, and Swigonski (2016) conducted a qualitative 
semi-structured interview-style study that utilized the Pediatric Quality of Life 
Inventory (PedsQL) NF1 model.  This tool helped collect comprehensive 
descriptions from pediatric NF1 patients and families, pediatric participants were 
divided into age groups (5-7yrs, 8-12yrs, 13-17yrs, and 18-25yrs) and interviewed 
in person while parents of these participants were interviewed via phone (n=41). 
 Semistructured and open-ended questions were used to elicit narratives regarding 
how NF1 affects physical symptoms, treatments, psychological and school 
functions.  Narratives were tape-recorded and transcribed.  Results suggest that 
several NF1 patients and families have to explain NF1 to others because it is 
poorly understood in the community.  Several participants mentioned having a 
number of worries about NF1, mostly about the uncertainty of it progressing.  The 
authors created a framework to include the five most important concerns from 
participants:  pain, social functioning, physical limitations, stigma, and emotional 
distress.  This study highlights the need for frequent quality of life nursing 
assessments for NF1 patients so that these concerns can be addressed and 
supported.  
 
Baker (2011) conducted a cross-sectional survey design study in the UK 
that examined 368 nurses (n=368) and used a 30-item, anonymous questionnaire. 
 The survey was distributed to all nurses hired at a specialist hospital during 2008, 
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and was sent to the nurses’ homes in the public mail.  Subjects had 5 weeks to 
complete the questions and return the survey in a previously stamped envelope. 
 26 questions were closed statements, and 4 questions were open-ended.  91% of 
respondents claimed that nurses require access to specialist education and training 
that focuses on neurological conditions.  Nurses often perceived that they were ill 
prepared for practice in any setting or specialty.  This study raises the possibility 
that nurses in the U.S. may be experiencing similar degree of preparedness 
towards NF1 patients, and would gain confidence if additional training were 
provided.   
Chen and Kim (2014) developed a survey to assess the genomic education 
training needs among health educators.  The subject sample was formed by 
purchasing a list of people who were Certified Health Education Specialists 
(CHES), which is a certification granted by the National Commission for Health 
Education Credentialing, Inc (NCHEC).  7,626 health educators with CHES 
designation were invited to take part in this study (n=7,626) and 980 health 
educators chose to participate.  The questionnaire included questions items 
regarding previous training in genomics, self-reported genomic knowledge, beliefs 
and values of incorporating genomics into health promotion and practice, desired 
genomic training, and preferred delivery methods.  60.6% of respondents claimed 
they had no or very little genomic knowledge.  5.6% stated to have quite a lot or 
an extensive amount of knowledge.  The preferred methods for genomic training 
and education were (in order of popularity) continuing education, web-based 
training, professional conferences, workshops, interpersonal communication, peer-
reviewed articles, in-service training, and teleconferences.   This study had low 
response rate (12.9%) and those that participated might be biased towards learning 
about genomics training compared to others who did not participate.  These might 
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have limited the study’s findings, but was able to conclude that overall there is a 
need for genomic education even amongst health educators in the U.S.  
Gallo, Angst, Knafl, Twomey, and Hadley (2010) set out to examine the 
views of health care professionals regarding how to care for patients and families 
with genetic disorders.  Semi-structured interviews were used to collect 
information from 37 health professions in 3 clinical sites in the midwest, U.S.  A 
goal of this study was to see how health professionals are individualizing care and 
genetic information for patients with genetic disorders. Professionals were 
recruited for this study after they were recruited to partake in a larger study 
involving parents.  Eight registered nurses took part in these interviews (22% of 
participants), and they all had some experience with either phenylketonuria, sickle 
cell disease, cystic fibrosis, neurofibromatosis, hemophilia, thalassemia, Marfan 
syndrome, or von Willebrand disease.  Results conveyed four major themes: (1) 
sharing information with parents, (2) taking into account parental preferences, (3) 
understanding of the condition, and (4) helping parents inform others.  The nurses 
emphasized their role of reinforcing information from the physicians, but also 
concentrating on care coordination, clinic resources, and anticipatory guidance 
education.  One nurse mentioned that parents are overwhelmed at times, and it “is 
our role to help them process things they get from outside.”  Another nurse states 
that he or she is involved in translating genetic information so that families can 
understand, and offering reassurance when interpreting a diagnosis.  While this 
study examined the interdisciplinary efforts from physicians, genetic counselors, 
nutritionists, and social workers in addition to nurses, it is able to conclude that 
health care professionals play a central role in assisting families of children with 
genetic conditions in understanding the condition.   
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These literary examples consider several aspects of nursing preparedness, 
knowledge, and competency in relation to caring for patients with genetic and 
genomic conditions.  It is clear from these articles that nurses are unfamiliar with 
the baccalaureate genetic essentials and competencies expected of all nursing 
graduates.  This unfamiliarity translates to a lack of core nursing skills and a poor 
understanding of these patients’ basic needs.  In addition, the literature shows that 
nurses perceive themselves as being unprepared for genetic and genomic patient 
care and recognize their own professional deficiencies.  Possibly the most 
compelling evidence of this shortcoming stems from the families and patients who 
feel that health care providers misunderstand these disorders.  They state that the 
most frustrating part of their medical experience is when encountering providers 
who are unfamiliar and uneducated about their child’s disease.  Other literature 
explores ways in which genetic and genomic education can be promoted, some 
suggest long term interventions and having leadership involved in advocacy and 
endorsement.  It is clear that heavy genetic academic content is shown to improve 
genetic knowledge, and yet there have been no proposed standardized educational 
tools that attempt to achieve this.  The responsibility of health care professionals is 
to understand these conditions to the extent set forth by the AACN and the ANA, 
so that nurses have competencies and confidence to safely and appropriately care 
for these patients.  The review of the literature above shows that improvements are 
still needed before such can be achieved.  
Conceptual Framework 
The nursing NF1 education project was based from the idea that adult 
nurses would gain knowledge about NF1 and the NF1 nursing role by using a self-
guided educational tool.  The theoretical/conceptual basis for this project 
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integrates Malcolm Knowles’ adult learning theory that establishes the conditions 
under which adult learning can be maximized (Hartzell, 2007).  In 1974, Malcolm 
Knowles coined the term andragogy to mean the art and science of adult learning 
(Kenner & Weinerman, 2011).  He felt adults made up a distinct learning 
population that was unique to youth learners (a science termed pedagogy), and 
was characterized by six assumptions (Knowles, Holton III, & Swanson, 2005): 
 (1) adults know why they need to learn something before undertaking to learn it.  
Thus, when educators emphasize the “need to know” to adult learners, 
effectiveness of teaching improves.  (2) Adults have a self-concept of being 
responsible for their own decisions, and therefore strive to be self-directing 
learners rather than dependent learners.  If educators can harness and engaged 
experience with the learners, rather than feeding them information, students will 
be more engaged.  (3) Adult learners have lived through experiences that youth 
learners have not.  These experiences serve as a lens through which context can be 
applied, and the adult learner will grasp concepts more strongly once experience 
has been applied.  (4) Adults possess a readiness-to-learn that youth learners do 
not always have, suggesting that there is an importance to the timing of certain 
information. (5) Adult learners consider the orientation to learning, meaning that 
they grasp the reasoning that makes a lesson applicable to real life.  And (6) adults 
carry an external motivation to learn new information, tasks, or skills.  Typically 
this motivation comes from a salary promotion, better job, or improved quality of 
life (Knowles et al., 2005).   
These assumptions from Knowles’ theory of the adult learner can be 
applied to this subject population used in the nursing NF1 education project. 
 Here, the participating subjects were oncology infusion center nurses with BSN 
degrees.  The introductory consent form and the educational tool attempt to 
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address these six assumptions by highlighting the reasons why it is important they 
gain NF1 knowledge.  The participating hospital plans to relocate all pediatric 
NF1 patients to a new department where they will receive care and care 
coordination.  This new department, the oncology infusion center, is composed of 
oncology nurses with varied NF1 patient experience.  As pediatric NF1 patients 
transition to the infusion center, nurses will understand the need for preparedness 
and a sense of purpose when caring for these patients.  By using Knowles’ theory 
of andragogy, this motivation will aid in the knowledge retention when reviewing 
the NF1 educational tool and adult learning can be maximized.  The adult learning 
theory will have many opportunities to be used as adult healthcare professionals 
continue to face ever changing technology, genetic discoveries, and medical 
advancements, and thus continual opportunities to learn (Clapper, 2010).  By 
understanding the conditions that maximize adult learning, not only will evidence-
based practice be promoted but employee retention will improve and health care 
errors reduced (Clapper, 2010).  
 
   
CHAPTER 3: METHODOLOGY 
The nursing NF1 education project used a cross-sectional, descriptive 
research design that involved a pre-test survey, a self-guided educational tool, and 
a post-test survey.  Approval to conduct this study was granted by the IRB at 
Stanford University and by the University of California/Fresno State.  
Participating subjects consented to the nursing NF1 educational project within the 
introductory email.  Each subject was given 3 weeks to complete all three 
components:  the pre-test, the educational tool, and the post-test.  Data from the 
pre-test surveys were compared to data from the post-test surveys in order to 
determine if there was a change in nursing NF1 knowledge or NF1 knowledge 
perception after having completed the educational tool.  After analyzing the results 
of this project, we anticipated the need for more substantial nursing education 
relating to NF1.  We predicted that these findings would effectively contribute to 
NF1 nursing education and to the efforts of meeting the nursing competency 
essentials outlined by the ANA and AANC (ANA, 2009; AANC, 2008).  With 
supporting data of its effectiveness, this tool could then be used by nurses at other 
institutions to improve nursing NF1 knowledge and ultimately improve NF1 
patient care worldwide.  
Participants 
Inclusion criteria were limited to BSN prepared nurses within the oncology 
infusion center.  Medical assistants, physician assistants, nurse practitioners, 
physicians and clinical nurse specialists were excluded.  The infusion center nurse 
manager identified all infusion center nurses, which totaled 50 eligible subjects 
(n=50), and provided each of their email addresses.  Permission was given by the 
nurse manager to use these email addresses, as well as permission for subjects to 
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participate in the project using work-hours.  Within the surveys, subjects self-
identified as infusion center nurses and stated their experience working with NF1 
pediatric patients.  The subject recruiting process used email as a way to request 
subject participation, and within the email was a statement explaining the subjects’ 
participation as voluntary and that no compensation will be provided.  Subjects’ 
email addresses were not identifiable on the pre- or post-test survey responses, and 
therefore participation was anonymous to examiner.  It was anticipated that each 
subject would benefit educationally from this study by having completed the 
nursing NF1 educational tool (PowerPoint).  The intent of the study is that each 
subject would gain knowledge relating to the pediatric NF1 population, which 
would increase understanding, competency and comfort when caring for these 
patients.  Pediatric NF1 patients seeking care at this children’s hospital will benefit 
from this study because the NF1 nurse participants will have been exposed to NF1 
education, helping to boost their NF1 care, confidence and competency.   Greater 
knowledge of genomics and genetics will enable nurses to feel more comfortable 
and be more proficient in providing holistic care for patients and families with 
genetic conditions (Munroe & Loerzel, 2016). 
Potential Risks: 
Nurses asked to participate in the study may not have available time during 
work hours to complete the pre-test, educational tool (PowerPoint), and post-test. 
 In this instance, nurses were encouraged to complete these components 
voluntarily outside of work time.  Nurses that were unable to find time to 
participate were not used as subjects for this study.  To minimize the risk of 
experiencing potential psychological anxiety throughout this study, subjects were 
informed of the voluntary and anonymous nature of the project.  To ensure 
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confidentiality, subjects’ email addresses were not associated with survey data. 
 Once surveys had been completed, data was stored in Qualtrics electronic 
software without subjects’ names or other identifying information, and with only 
the examiner having access.  The IRB mandated 12 months of Qualtrics data 
storage, to which only the author has access.  Data will be erased from Qualtrics 
by the examiner at the completion of this project or after 12 months, whichever 
occurs first.  This study expires on September 22, 2019.  
 Sampling Procedure 
Each subject was sent an individual email (see Appendix A).  All emails 
were sent out simultaneously.  The email contained a short paragraph describing 
the study instructions.  The instructions listed four steps for the participant to 
follow:  (1) read and sign the NF1 consent form (word document attachment, see 
Appendix B), (2) complete the pre-test survey (hyperlink to Qualtrics survey, see 
Appendix C), (3) review the Power Point educational tool (attachment, see 
Appendix D), (4) and complete the post-test survey (hyperlink to Qualtrics survey, 
see Appendix E).  Subjects had the option of completing these steps from a 
computer or a cell phone that utilized internet and had access to work emails.  The 
pre-test and post-test were identical, and consisted of 21 questions using Likert 
scale and multiple choice formats so as to collect nominal and categorical data.  
Subjects were able to manually click through the PowerPoint educational tool at 
his or her preferred pace, and data was anonymously and automatically saved in 
Qualtrics.  The survey was accessible to the participants for 3 weeks (21 days).  
Reminder emails were sent once weekly during this period to help achieve higher 
response rates.  Data collection occurred by downloading results from Qualtrics, 
and a consulting statistician assisted with statistical analyses.  Each subject had 
 24 24 
single-use participation which was ensured by asking identifying questions at the 
beginning of each pre-test and post-test (questions such as “what was the name of 
the street you grew up on?” and “what was the name of your first pet?”).  No 
duplicate answers to these questions were found in any of the surveys.  Subjects 
were not financially compensated for taking part in the research study. 
Measures 
The outcomes for the nursing NF1 education project were: (1) create a 
nursing NF1 education tool that is shown to be effective in improving nursing NF1 
knowledge and nursing NF1 knowledge perceptions, (2) support the mission of the 
Children’s Tumor Foundation to drive research, expand knowledge and advance 
care for the NF community (CTF, 2016), and (3) contribute to the nursing 
educational guidelines set forth by the AACN aiming to equip nurses with an 
academic background so that they may provide safe and appropriate care for all 
patients with genomic and genetic conditions (AACN, 2008).  To meet these 
objectives, pre- and post-test surveys were given to 50 nurses that were to be 
completed before and after reviewing the NF1 educational tool, respectively.  The 
pre- and post-test surveys were identical and contained 21 questions total.  One 
question identified the survey as being either pre-test or post-test, one question 
asked for identifying information needed to associate each subjects’ pre- and post-
test while keeping anonymity of each subject (asked for childhood street name, 
and name of first pet), and three questions asked about professional experience 
(years working as a nurse, years working in pediatric oncology, and former NF1 
education).  Three questions asked subjective information relating to nurses’ 
perceptions:  rate your current NF1 knowledge (Likert scale), rate your perception 
on 13 various NF1 topics (Likert scale poor, good, excellent), and if you currently 
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feel prepared to care for NF1 patients (Likert scale).  The remaining 13 questions 
were multiple choice questions testing for objective NF1 knowledge.  See Table 1 
for the breakdown in test questions.  The nursing NF1 education project was 
conducted entirely electronically using Microsoft Outlook (email), Qualtrics 
(online pre-test and post-test), and Microsoft PowerPoint (NF1 educational tool). 
Table 1. Breakdown of Pre-Test and Post-Test 
Type of Test Question Number of Test 
Questions 
Question Descriptions 
Distinguish pre- and post-
test 
1 -choose either pre-test or post-test 
Anonymous subject 
identification 
1 -street name & name of first pet 
Former education 
(Background information) 
3 -former NF education (L) 
-total RN experience (MC) 
-total pediatric oncology experience (MC) 
Subjective 3 -rate current NF knowledge (L) 
-rate preparedness to care for NF1 patients (L) 
-rate perception of understanding of 13 different 
NF1 topics (L) 
Objective NF1 knowledge 13 -diagnosis criteria (MC), 1 
-types of NF (MC), 1 
-genetic characteristics (MC), 2 
-clinical presentation (MC), 3 
-NF1 treatment (MC), 1 
-NF1 care management (MC), 1 
-NF1 nursing role (MC), 2 
-psychosocial (MC), 2 
L = Likert 
MC = multiple choice 
 
 
 
   
CHAPTER 4: RESULTS 
Fifty infusion center nurses were asked to take part in the study by way of 
an invitational email.  Twenty-five respondents completed the pre-test (53.19%) 
and 22 completed the post-test (46.81%).  Only subjects that had completed both 
the pre-test and post-test were considered in this project, and therefore the 3 pre-
tests that had no associated post-tests were discarded and not included in the 
statistical analysis.  This resulting in a 46.81% overall response rate with n=22 
(pre-test) and n=22 (post-test).  This led to a small sample size.   
Nursing Background Results 
The majority of participants had been a registered nurses for over 5 years 
(50.00%), with only 2 newly graduated participants with less than one year 
experience (9.09%).  36% of respondents had over 5 years of experience working 
with pediatric oncology patients.  When asked in the pre-test about the degree of 
former NF1 education received, 5 nurses (22.73%) stated no education, 6 
(27.27%) claimed they had heard of NF1 in nursing school but don’t remember 
anything, 4 (18.18%) remembered learning about NF1 in neurology lectures, 2 
(9.09%) remember NF1 from genetics lectures, and 5 (22.73%) only learned from 
experience while working with these patients (see Fig. 1). 
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Figure 1.  Nursing Background Information 
Objective and Subjective Information 
Twenty-two students were tested before and after NF1 educational tool 
training in hopes to determine if the educational tool impacted the post-test results. 
 These tests were of two types.  The first was a set of objective test questions.  The 
second was a set of subjective test questions measuring the perception the students 
had in their ability and confidence in caring for pediatric patients with NF1.  With 
a small sample size such as we have, real effects may be masked in the sense that 
it is difficult to statistically find effect unless they are really pronounced.  
However, we found that there were clear improvements (comparing the post-tests 
with the pre-tests) in the mean scores.  For the effects of the years of experience as 
a registered nurse, there were no statistically significant effects in either the 
objective or subjective tests, whether the measurements are the initial mean scores 
or the improvements.  On the other hand, the effects of the years of experience in 
pediatric oncology, while not formally statistically significant, were close to 
significance with regard to objective initial scores and improvement in scores. 
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 Those with greater experience tended to have higher objective scores followed by 
smaller improvements.  They also tended to have smaller subjective 
improvements.  The effect of prior NF1 experience was not found to be 
statistically significant for either the objective or subjective tests.  The correlations 
between the objective and subjective test scores, either the initial scores or the 
improvements were not found to be statistically significant. 
Improvement in Scores 
The objective scores are the numbers of correct answers for the 13 NF1 
knowledge questions for both pre-test and post-test.  We observe that the post-test 
had higher scores than the pre-test by an average of five points, averaged over the 
22 students. We are testing that the true mean difference is zero. This is done by a 
paired t test.  The results for the objective scores are summarized in Table 2.  The t 
statistic is 5.54.  This corresponds to a p-value of 0.000.  Any p-value less than 
0.05 is considered to be statistically significant.  Thus, we find that the 
improvement is statistically significant. 
Table 2.  Comparison of Objective Scores, Before and After 
 
  Before After 
Means 17.55 22.55 
St. Dev. 4.09 2.94 
df 21   
t 5.54   
p 0.000   
 
The subjective scores are the sums of all nursing perception questions, both 
pre-test and post-test.  The results for the subjective scores are summarized in 
Table 3.  The t statistic is 8.00.  This corresponds to a p-value of 0.000.  Thus, we 
find that the improvement is statistically significant. 
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Table 3.  Comparison of Subjective Scores, Before and After 
  Before After 
Means 15.82 26.18 
St. Dev. 3.61 5.69 
df 21   
t 8.00   
p 0.000   
 
The observed objective mean scores for both before and after are plotted in 
Figure 2.  The observed subjective mean scores for both before and after are 
plotted in Figure 3.   
 
 
 
Figure 2.  Objectives Means, Before and After 
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Figure 3.  Subjective Means, Before and After 
Effect of Years of Experience 
The variable “years of experience as a registered nurse” is evaluated both as 
an effect on initial scores and an improvement in scores.  The questionnaire lists 
intervals for the years of experience.  For purposes of the analysis, these are then 
converted into mid-points as listed in Table 4.  The open-ended range of five years 
and more is converted to seven years. 
Table 4.  Conversion of Years. 
 
Survey Mid-point 
Less than 1 0.5 
1 to 2 1.5 
3 to 5 4.0 
More than 5 7.0 
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Linear regressions are done for RN experience against the objective and 
subjective initial scores and improvement.  The intercept and slope define the 
linear regression equation.  y = Intercept + Slope*x, where y is the score and x is 
the number of years of RN experience.  For example, for the first line, y = 14.93 + 
0.554*x, where y is the initial score and x is the number of years of experience as 
an RN.  A zero slope indicates that the years of experience has no effect.  We are 
testing that the true slope is zero.  A p-value below 0.05 indicates that we should 
reject the hypothesis of zero slope (that is, no effect).  All p-value exceed 0.05.  
This means that we cannot find a statistical effect due to RN experience. 
Table 5.  RN Experience Regression 
 
  Intercept Slope t p 
Objective Initial 14.93 0.554 1.65 0.115 
Objective Improvement 6.68 -0.354 -0.98 0.339 
Subjective Initial 17.10 -0.271 -0.87 0.393 
Subjective Improvement 9.41 0.202 0.38 0.707 
 
The same regressions were done by the years of experience in pediatrics 
oncology.  While we find no statistical significance in any of the regressions, three 
of the four regression had low p-values slightly greater than 0.05.  This suggests 
that the relatively small sample size of 22 students could be masking the real 
effect. 
From the signs of the slopes, it appears that more experience leads to higher 
initial objective scores and then smaller objective score improvements.  Similarly, 
more experience leads to smaller improvements in the subjective scores. 
Table 6.  Pediatric Oncology Experience Regressions 
  Intercept Slope t p 
Objective Initial 14.92 0.634 1.85 0.079 
Objective Improvement 7.63 -0.635 -1.78 0.090 
Subjective Initial 16.30 -0.117 -0.36 0.723 
Subjective Improvement 14.66 -1.039 -2.08 0.051 
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Figures 4, 5, and 6 show plots of the three most clear-cut regressions.  The 
blue dots are the observed data and the red line is the fitted regression line. 
 
Figure 4.  Experience in Pediatric Oncology Predicting Improvement in 
Subjective Scores 
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Figure 5.  Experience in Pediatrics Oncology Predicting Initial Objective 
Scores 
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Figure 6.  Experience in Pediatrics Oncology in Predicting Improvement in 
Objective Scores 
Effect of Prior NF 1 Experience 
 
We next examine the effect of prior NF 1 education.  The five levels are 
coded 1 through 5 as described in Table 7. 
Table 7.  Coding NF1 Education 
Level NF 1 Education 
1 No education 
2 Learned in school, but can't remember 
3 Learned in neurology class 
4 Learned in genetics class 
5 Learned from experience 
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The improvement in objective scores is summarized by the mean 
improvements for each of the five levels in table 8.   
Table 8.  NF1 Education versus Improvement in Objective Scores 
 
NF 1 Education Means Count 
1 3.25 8 
2 3.83 6 
3 5.50 2 
4 7.67 3 
5 9.00 3 
 
 A one-factor analysis of variance (ANOVA) was performed to test if the 
true improvement means are all equal.  The p-value of 0.222 indicates that we 
cannot reject this hypothesis.  Thus, we find no effect due to NF 1 education level. 
Table 9.  Analysis of Variance for NF1 Education versus Improvement in 
Objective Scores. 
 
Source of Variation SS df MS F p 
Between Groups 102.5 4 25.63 1.59 0.222 
Within Groups 273.5 17 16.09     
Total 376 21       
 
Tables 10 and 11 list the analogous results for the improvement in 
subjective scores.  Again, we find no statistically significant effects due to prior 
NF 1 education level. 
Table 10.  NF1 Education versus Improvement in Subjective Scores 
NF 1 Education Means Count 
1 11.29 8 
2 5.00 6 
3 8.00 2 
4 11.50 3 
5 13.50 3 
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Table 11.  Analysis of Variance for NF1 Education versus Improvement in 
Subjective Scores 
Source of Variation SS df MS F p 
Between Groups 165.8 4 41.45 1.50 0.264 
Within Groups 332.4 17 27.70     
Total 498.2 21       
 
Correlations Between Objective and Subjective 
Scores  
A correlation coefficient between two variables is a number between -1 and 
+1.  A correlation of +1 indicates perfect correlation, meaning that if you know 
one of the variables, you know the other.  A correlation of 0 means that the two 
variables are unrelated.  A correlation of -1 means that they are perfectly related, 
but go in opposite directions.  We look at the correlation between the objective 
and subjective scores, with respect to the initial scores as well as the improvement.  
These correlations are summarized in Table 12.  The p-values indicate that these 
correlations are not statistically significant. 
Table 12:  Correlations between Objective and Subjective Test Scores 
Pairs Correlation p 
Initial Objective and Subjective 0.101 0.656 
Improvement Objective and Subjective 0.287 0.195 
 
 
 
   
CHAPTER 5: CONCLUSION 
Discussion 
The results from the pre-test and post-test surveys revealed information 
about several aspects of nursing NF1 knowledge and education.  When asked 
about former NF1 education, the majority of nurses claimed to have no education 
(36.36%).  Twenty-seven percent of the participants stated to have heard about 
NF1 in nursing school but did not remember anything, and 18.18% said they only 
learned about NF1 from prior experience working with NF1 patients.  The 
smallest percentages of nurses remembered learning about this population in either 
neurology lectures (9.09%) or genetics lectures (9.09%).  When considering the 
prevalence of pediatric NF1 and the likelihood of encountering an NF1 patient 
while working as a nurse, these reports of NF1 education are surprising.  This may 
be explained by the length of time since graduating from an academic nursing 
institution seeing as how 50% of the subjects had been a nurse for >5 years and 
may not remember former NF1 education.  Additionally, the majority of 
participants had worked specifically in a pediatric oncology department for >5 
years (36.36%) and may not utilize NF1 knowledge regularly.  While the AACN’s 
Essentials of Baccalaureate Education for Professional Nursing Practice 
mentions the responsibility of nursing baccalaureate programs to prepare 
graduates to be able to assess predictive factors such as genetics, academic 
programs may neglect to cover certain content (AACN, 2008).  With so many 
genetic disorders to include in undergraduate nursing curricula, nursing instructors 
may not be choosing to discuss NF1 directly.  Pre-test results indicate that 
approximately one third (36.36%) of nurses responded “definitely not” when 
asked how prepared they feel to adequately care for pediatric NF1 patients, one 
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third (31.82%) chose “not really” and one third (31.82%) “yes, but I’d like more 
education.”  None of the subjects responded “Yes, I feel confident.”  With a 
generalized need to equip nurses with genomic and genetic competencies, it is 
particularly indicated within a setting like the infusion center at which NF1 
patients will receive care.  
Results also helped determine the effectiveness of the NF1 educational tool 
(Power Point).  In efforts to meet the nursing NF1 education project outcome of 
creating an effective nursing educational tool, responses from the pre-test were 
compared to those from the post-test to determine if, indeed, the educational tool 
improved nursing NF1 knowledge.  The mean objective score, as well as the mean 
subjective score, both improved from pre-test (17.55) to post-test (22.55) with 
statistical significance, suggesting that nurses gained NF1 knowledge by 
reviewing the NF1 educational tool.  The subjective mean pre-test score (15.82) 
significantly increased with the post-test (26.18) as well, telling us that the 
educational tool succeeded in effectively improving nursing NF1 knowledge 
perceptions and confidence.  The project’s goal of creating a NF1 educational tool 
that demonstrated effective improvements in nursing NF1 knowledge and nursing 
NF1 knowledge perceptions was met.   
Interestingly, the number of years with registered nursing (RN) experience 
nor the amount of prior experience working with NF1 patients had a significant 
effect on mean objective or mean subjective scores.  The years of RN experience 
or NF1 experience did not affect the amount of improvement in scores between 
the pre- and post-tests.  However, the years experience working with pediatric 
oncology were related to the improvement in subjective scores, as well the 
objective initial and objective improvement scores.  The more years of experience 
working with pediatric oncology patients resulted in higher objective scores and 
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then smaller improvements.  These were all not quite significant at the 5% 
significance level, but were close.  It may be that the relatively small sample size 
made it difficult for a real effect to be formally detected.  It is unclear the reason 
for this near-significant statistical finding.  Possibly nurses with oncology 
backgrounds have exposure to additional training or education regarding genetics. 
 Cancer nursing courses have been used as platforms to introduce nursing 
genomics and genetics, based off the fact that cancer is essentially inseparable 
from the genetics concepts (Kiernan & Vallerand, 2016).  Cancer education has 
become a mainstream topic in undergraduate nursing curricula and therefore 
incorporating genes and gene expression into the standard malignancy lectures is 
logical.  Oncology courses have been used as a way to meet genetic education 
requirements stated in the AACN nursing baccalaureate guidelines (Kiernan & 
Vallerand, 2016; AACN, 2008).  While specific NF1 information may not have 
been reviewed in previous academic settings, nurses with greater amounts of 
exposure to the oncology profession may be applying genetic nursing knowledge 
to the NF1 population.  
The correlation between nursing NF1 knowledge and nursing NF1 
knowledge perceptions were found to be insignificant, both in overall scores 
(correlation = 0.101, p=0.656) as well as in score improvement levels (correlation 
= 0.287, p=0.195).  This suggests that nursing NF1 intelligence does not relate to 
nursing NF1 confidence, comfort, or sense of preparedness.  It is reassuring that 
when asked “Do you feel prepared to adequately care for the NF1 patients in the 
infusion center?,” the majority of pre-test responses (36.36%) claimed “definitely 
not” while the majority of post-test responses (52.27%) chose “yes, but I’d like 
more education.”  By having a larger sample size, we may have been able to 
statistically demonstrate that nurses acquired more confidence to care for NF1 
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patients after having completed the NF1 educational tool.  The same phenomena 
occurred with nursing perceptions of their understanding of the nursing role in 
NF1 care.  81.82% of nurses on the pre-test stated “poor,” 18.18% chose “good” 
and 0% selected “excellent.”  On the post-test, 45.45% “poor,” 47.43% “good” 
and 6.82% “excellent.”  While the nurses’ perception of the nursing role improved 
after utilizing the educational tool, the difference was not significant to 
demonstrate actual change.  This reinforces the importance of a larger sample size.  
Limitations 
While the nursing NF1 education project was able to contribute to the 
knowledge base of infusion center nurses as they prepare to care for pediatric NF1 
patients, limitations are present in this study.  The most considerable limitation is 
the study’s small sample size, which prohibited the statistical analysis from 
concluding information about the effectiveness of the NF1 educational tool, 
nursing NF1 knowledge, and nursing NF1 knowledge perceptions.  It is not clear 
if nurses were motivated to participate in this survey for there was no 
compensation involved.  In addition, the subjects were from one geographical 
location, and from the same department all within the same hospital.  This hinders 
the ability to generalize the information collected in this project to other nursing 
departments across California and in other states.  Additionally, there was no pilot 
study conducted to test the validity or difficulty level of the test questions.  It 
would have been helpful to initially administer the pre-test, educational tool, and 
post-test to a small sample of non-nurses and nurses.  The results from this pilot 
study would help determine whether the test questions were too easy or difficult, 
and how scores compare between the general public and the nursing workforce. 
 This information could then gauge the test questions that were ultimately used for 
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the pre-test and post-test within this project.  Another limitation was the lack of 
post-test questions that related to the nurses’ opinions of the educational tool 
directly.  Information regarding how well they navigated through the educational 
tool PowerPoint, if they had any unanswered questions about the presented 
information, or their general opinion about the electronic self-guided PowerPoint 
learning method, would have provided insight into this teaching style.  Lastly, one 
more limitation to this project was the inability to compare the effectiveness of 
this NF1 educational tool to another pre-existing tool.  In Munroe and Loerzel’s 
2016 study that assessed nursing student’s knowledge of genomic concepts by 
using the Genomic Nursing Concept Inventory (GNCI), authors were able to 
compare their results (45% on pre-test to 50% on post-test) to a previous study that 
measured knowledge gain from the GNCI in 2013 (44% on pre-test to 79% on 
post-test), (Munroe & Loerzel, 2016).  Because there exists no other educational 
tool to measure nursing NF1 knowledge, a similar comparison was unattainable.    
Conclusion 
In summary, nurses are expected to perform essential genetic and genomic 
competencies and be equipped to provide safe and appropriate care for all patients 
with genomic and genetic conditions (ANA, 2009; AACN, 2008).  Despite this 
mandate, it is difficult to find examples in the literature that demonstrate these 
competencies in action within the clinical setting (Kiernan & Vallerand, 2016).  
NF1 is a genetic disorder affecting approximately 1 in 3,000 people and requires a 
multidisciplinary team of medical professionals to meet the recommended 
management guidelines (CTF, 2016).  There is a likelihood that pediatric nurses 
will, at some point in their careers, encounter the opportunity to care for an NF1 
patient.  With the use of an effective nursing NF1 educational tool, nurses can 
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familiarize themselves with the disorder, gain confidence in providing care to this 
population, and ultimately meet the genomic and genetic competencies established 
by the ANA and the AACN.   
This project set forth to create such an educational tool whereas one 
currently does not exist, hoping to achieve three outcomes:  (1) produce an 
effective educational tool that improved nursing NF1 knowledge and nursing NF1 
knowledge perceptions, (2) support the mission of the Children’s Tumor 
Foundation to drive research, expand knowledge, and advance care for the NF 
community, and (3) contribute to the educational objectives of the AACN by 
achieving the essential nursing competencies expected of all nursing graduates. 
 While an educational tool was created that was shown to be significantly effective 
in improving nursing NF1 knowledge and NF1 knowledge perceptions, a larger 
sample size is needed to determine correlation and relevance to previous NF1 
education, nursing experience, and overall comfort in caring for these patients.  
Exposing nurses to the educational tool, however, contributes to the academic 
efforts of enhancing nursing awareness of the NF1 population and medical needs, 
fulfilling the intentions of the CTF.  The educational tool also aligns with AACN’s 
foundational outcome competencies deemed essential for all nurse baccalaureate 
graduates, regardless of specialty or focus (AACN, 2008).  This document 
mentions genomics or genetics skill sets in 4 areas.  Within Essential I, nurses are 
expected to endure a liberal education involving science, the arts, and life science 
such as biology and genetics.  Within Essential V, nurses are expected to 
understand a broader context of health care as it impacts social trends, such as 
within the ever changing science of genomics and genetics.  Within Essential VII, 
it states that the “baccalaureate program is expected to prepare the student to 
assess protective and predictive factors, including genetics, that influence health of 
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individuals, families, communities, and populations,” (AACN, 2008, pg 24).  And 
within Essential IX, the AACN states that both genetics and genomics are fields 
where knowledge is constantly expanding.  Nurses should be cognizant of tailored 
therapies designed to improve patient care outcomes,” (AACN, 2008, pg 30).  
Sharing the same educational goals as these essentials, the nursing NF1 
educational tool contributes to the overall mission of improving nursing genetic 
and genomic knowledge so that nurses are empowered to take part in the health, 
prevention, screening, treatment selection, treatment effectiveness, and 
constructed pedigrees from family histories (AACN, 2008).   
General themes arising from this project include awareness of the ongoing 
need for nursing knowledge assessments.  It is evident that nurses often learn care 
techniques on the job or from colleagues.  Whether in a structured academic 
setting or not, nurses should be routinely assessed for confidence and competency 
with tasks involving patient care.  This will determine the need for further 
education, investigate the use of evidence-based research in everyday practice, and 
monitor patient safety.  In addition, the nursing NF1 education project emphasizes 
the ongoing need to review the expected nursing competencies outlined by the 
ANA and AACN.  It is critical that both nursing schools and nurse managers 
remain versed in the expectations of nursing competencies, including those 
relating to genetic and genomic skills, so that nurses not only receive the expected 
education, but that it translates to clinical practice.  A final theme to acknowledge 
is one that highlights the importance of listening to patients’ needs.  Parents with 
children who have NF1 described feeling frustrated and angry because of 
experiences with health care professionals who had not heard of NF1 or who 
misunderstood it (Barke et al., 2016).  Members of the medical community should 
interpret this and recognize the professional responsibility and obligation of 
 45 45 
educating themselves in order to help provide comfort and reassurance to these 
families.   
Recommendations for future expansion of this project include testing the 
effectiveness of this nursing NF1 educational tool to larger sample sizes so as to 
extract a more meaningful and significant conclusion relating to its ability to 
improve NF1 knowledge.  With stronger evidence to suggest that this tool 
achieves its goals, it could then be introduced to larger NF1 resource platforms 
such as the CTF and be incorporated in nursing school curricula.  Nurses will be 
able to reference this tool when seeking standardized NF1 knowledge and nursing 
guidelines, or potentially earn continuing education credits/units with its use.  The 
NF1 educational tool can ultimately contribute to nursing knowledge, help achieve 
competencies in alignment with the ANA and the AACN guidelines, and support 
nurses in providing appropriate care for NF1 patients.   
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Each subject was sent an initial introductory recruiting email on January 
14th, 2019.  The email was sent to the entire email distribution list of BCDH nurses, 
totaling 50 recipients.  The email contained an introductory paragraph, as well as 
instructions to follow if the subject chose to participate.  Attached to the email was 
a word document consent form, as well as a PowerPoint educational tool.  The 
pre-test survey and the post-test survey were accessed using hyperlinks, which 
were embedded into the body of the email.  See below for a copy of the email: 
-------------------------------------------- 
 
 
Hello BCDH nurses, 
You have been invited to participate in a brief study looking at nursing knowledge of 
pediatric NF1 patient care.   This study is being done as part of my DNP project at UC-
Fresno/San Jose.  Please follow the steps below.  Complete participation in this study will 
take approximately 30 minutes, and it will be available to you until Sunday Feb. 3, 2019. 
 Your involvement is greatly appreciated. 
  
1)     Read NF consent form (attached document) 
2)     Complete pre-test survey: 
   https://stanforduniversity.qualtrics.com/jfe/form/SV_4ZrMkEpNAafiZJX 
3)     Review educational tool (attached slide presentation): 
4)     Complete post-test survey:  
 https://stanforduniversity.qualtrics.com/jfe/form/SV_4ZrMkEpNAafiZJX 
  
  
For questions, please contact Samantha Ingerick, NP 
singerick@stanfordchildrens.org 
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CALIFORNIA STATE UNIVERSITY 
NORTHERN CALIFORNIA CONSORTIUM 
DOCTOR OF NURSING PRACTICE 
  
Caring for the Pediatric Neurofibromatosis Type-1 Patient: 
Improving Nursing Knowledge Through an Innovative Educational Tool 
  
You are being asked to participate in this research study because you a nurse within the 
Bass Center Day Hospital at Lucile Packard Children’s Hospital, and may be asked to 
care for children with neurofibromatosis type-1 (NF1).  The purpose of this research 
study is to evaluate nursing knowledge, and perceived nursing knowledge, of pediatric 
NF1 patient care before and after reviewing an NF1 educational tool (PowerPoint 
presentation). The responses to this study may help contribute to enhanced nursing NF1 
education and hopefully lead to increased competencies when caring for this population. 
 Please complete the pre-test survey, then review the PowerPoint educational tool, then 
complete the post-test survey.  The pre- and post-tests are each 21 questions and include 
Likert-scale, multiple choice, and ranking questions.  Your complete participation will be 
approximately 30 minutes.  Your participation is completely voluntary and your answers 
will be kept entirely confidential.  By completing the pre-test and post-test you give 
consent to participating in this investigational research study.  You have 3 weeks to 
complete all sections; starting from the time you received this email.  Thank you for your 
time, please click the pre-test link below if you wish to continue. 
  
Consent:  I consent to participating in the Pediatric NF1 Nursing Education study 
described above.  I understand that my participation is voluntary, and that my name and 
identifiers will be kept entirely confidential.   
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Pre-Test Survey / Post-Test Survey 
 
1) Is this your pre-test or post-test? 
1 = pre-test 
2 = post-test 
 
2) To familiarize yourself with the testing format:  Please answer the following 
two questions before beginning the survey:  
1 = What is the name of the street you grew up on? 
2 = What is the name of your first pet? 
 
3) How would you rate your current knowledge of neurofibromatosis type-1 
(NF1)? 
 1 = non-existent, I’ve never heard of NF1 
 2 = I’ve heard of NF1, but I don’t know much about it 
 3 = I’m familiar with NF1, I know basics about the disease 
 4 = Above average knowledge of NF1 
 5 = Highly educated on NF1 
 
4)  What former NF1 education have you received? 
 1 = no education 
 2 = I heard about in nursing school, but I don’t remember anything 
 3 = I remember learning about it in neurology lectures 
 4 = I remember learning about it in genetics lectures 
 5 = I only learned from experience while working with these patients 
 
5)  Please rank the following: 
 Poor Good Excellent 
Your current knowledge of Neurofibromatosis Type-1 
(NF1): 
   
Your current knowledge of caring for pediatric NF1 
patients: 
   
Your confidence in caring for pediatric NF1 patients:    
Your recognition skills of café-au-lait spots:    
Your comfort in talking with a family about their child’s 
genetic disorder: 
   
Your comfort in talking with a family about coping with 
their child’s NF1 diagnosis 
   
Your understanding of the nursing role with pediatric 
NF1 patients: 
   
Your understanding of why NF1 patients occasionally 
need chemotherapy 
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Your current knowledge of why NF1 patients are 
referred to ophthalmologists 
   
Your familiarity with NF1 diagnosis criteria    
Your current knowledge of the importance of pain 
assessments for pediatric NF1 patients 
   
Your ability to list 4 interdisciplinary medical teams 
involved in the care of pediatric NF1 patients 
   
Your ability to list 4 nursing interventions that can assist 
in the care of pediatric NF1 patients 
   
 
6)  Your experience working as a registered nurse: 
 A.  <1 year 
 B.  1-3 years 
 C. 4-5 years 
 D. >5 years 
 
7)  Your experience working within the pediatric oncology population: 
 A.  <1 year 
 B.  1-3 years 
 C. 4-5 years 
 D. >5 years 
 
8)  Do you currently feel prepared to adequately care for NF1 patients in the 
BCDH? 
 1 = No 
 2 = Kind of 
 3 = Yes, but I’d like more education 
 4 = Yes I feel confident 
 
9) The 3 types of neurofibromatosis (NF) are:     
 A.  NF type-1, NF type-2, and NF type-3 
 B. NF type-1, NF type-2, and schwannomatosis 
 C.  NF, ependymoma, and medulloblastoma 
 D.  neurofibromin type-1, neurofibromatosis type-1, and neurofibroma 
type-2 
 
10)  For a clinical NF1 diagnosis, a patient must have:   
 A. six or more café-au-lait macules and freckling in axillary or inguinal 
regions 
 B.  two or more neurofibromas or one plexiform neurofibroma 
C.  two or more List nodules 
 D.  optic glioma 
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 E.  osseous lesion 
 F.  first-degree relative with known NF1 
 G.  two or more of the symptoms listed above 
 
11)  NF1 is a genetic disease that occurs in patients as:  
 A. an autosomal dominant mutation in the NF1 gene 
 B. an autosomal recessive mutation in the NF1 gene 
 C. a spontaneous gene mutation 
 D. A or C 
 E.  A and C 
 
12)  Which of the following isn’t a potential presentation of NF1?  
 A. headaches 
 B.  neutropenia 
 C. learning disabilities/ADHD 
 D. precocious puberty 
 E. seizures 
 F. pain 
 
13)  Care for the NF1 patient can involve:    
 A. ophthalmologists, dermatologists, oncologists and neurologists 
 B. genetic medicine 
 C. orthopedic surgery  
 D. oncologists and cardiologists 
 E. all of the above 
 
14)  Patients with NF1 sometimes develop tumors (neurofibromas) that sometimes 
cover nerves in the body.  These tumors sometimes require the following 
treatment: 
 A.  bone marrow transplant 
 B.  chemotherapy, surgery, or surveillance scans 
 C.  splenectomy 
 D.  IVIG treatment with scans 
 E.  chemotherapy and splenectomy 
 
15)  Individuals affected with NF1 often report __ as major issues impacting their 
lives: 
 A. stigma 
 B.  loss of social role and social relationships 
 C. loss of physical attractiveness and normal body functions 
 D. decreased educational and financial opportunities 
 E. all of the above 
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16)  Patients and families affected by NF1 reported that the most frustrating aspect 
of their health care was: 
A. inexperienced health care professions who were unfamiliar with NF1 
B.  too many social and resources available  
C.  counting their café-au-lait spots 
D. getting MRI scans 
 
17) Which of the following are possible symptoms of NF1 (choose all that apply) 
 A. Visual impairment (optic glioma) 
 B. Head: macrocephaly, seizures, brain tumors, learning disabilities 
 C. Cardio:  high blood pressure 
 D.  Liver:  elevated ALT and AST liver enzymes 
E. Skin:  axillary and inguinal freckling, café-au-lait spots 
 F.  Bones:  pseudoarthrosis, bone deformities, scoliosis 
 F.  Tumors:  neurofibromas that may occur along the nerves 
 E.  Digestive tract:  stomach pain, constipation, vomiting 
 
18) As a nurse caring for pediatric NF1 patients, it is important to: 
 A. Inquire about skin changes, headaches, and changes in vision 
 B. Avoid touching café-au-lait spots for risk of contagion 
 C.  Measure head circumference of all pediatric NF1 patients  
 D. Know that all patients will present with identical NF1 symptoms 
 E. All of the above 
 F. A & C 
 G.  A & D 
 
19) The pediatric NF1 nursing role includes: 
 A.  Administering chemotherapy to all NF1 patients 
 B. Identifying and acknowledging any coping difficulties the family might 
have relating to NF1 diagnosis 
 C.  Avoiding the use of pain scales 
D.  Recommending that all pediatric NF1 patients receive specialized 
education for ADHD 
 
20)  Clinical changes that could be associated with NF1 presentation include: 
 A.  Recently painful “lump” underneath the skin 
 B.  Recent changes in vision 
 C.  Misalignment of the hips or scoliosis 
 D.  Recent onset headaches 
 E.  Difficulty focusing in school 
 F.  Fever 
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 G.  Elevated Blood Pressure 
21)  All pediatric NF1 patients will present with: 
A.  List nodules 
 B.  café-au-lait spots 
 C.  a segmental or germ line mutation 
 D. ADHD 
 E.  tumors 
 F.  all of the above 
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Public genomic and genetic educational resources for health care professionals 
Resource Contact Description 
Centre for 
Education in 
Medical Genetics 
http://www.bwhct.nhs.uk/ genetics-cemg-home.htm Develops, provides, and 
evaluates genetics education 
opportunities and resources 
Centre for 
Genetics 
Education 
http://www.genetics.com.au/ Education and service resources 
for patients and professionals 
Dolan DNA 
Learning Center 
http://www.dnalc.org Interactive, multimedia genetics 
education resources 
Foundation for 
Genetic 
Education and 
Counseling 
http://www.fgec.org Educational resources on 
genetics and common diseases, 
especially psychiatric disorders 
(bipolar disorder and 
schizophrenia) 
GenEd Project http://www.medicine. man.ac.uk/GenEd/ Education and research links 
related to European aspects of 
genetic services 
Genetics and 
Your Practice 
http://www. marchofdimes.com/ gyponline/index.bm2 Online modules for healthcare 
professionals designed for 
exploration of a topic rather than 
sequential presentation of 
material . . . Many excellent fact 
sheets and sample clinical forms 
Genetics in 
Clinical Practice: 
 A Team 
Approach 
http://iml.dartmouth.edu/ education/cme/Genetics/  
or  
http://www.acmg.net/ resources/cd-rom-01/ intro.asp 
Takes healthcare provider into a 
Virtual Genetics Clinic . . . 
Interactive virtual genetics clinic 
with case scenarios and case 
discussions . . . Target audience 
is primary care professionals 
Genetics in 
Primary Care 
http://genes-r-us. uthscsa.edu/resources/ 
genetics/primary_care.htm 
Training program curriculum 
materials 
Genetics in 
Psychology 
http://www.apa.org/ science/genetics/ homepage.html American Psychological 
Association's genetics site 
Genetics 
Education 
Program for 
Nurses (GEPN) 
curriculum 
resources 
http://www.cincinnati childrens.org/ed/ 
clinical/gpnf/default.htm 
Sample genetics nursing course 
syllabi and other genetics 
educational opportunities and 
resources for nurses, as well as 
links to instructional resources 
used in GSI (Genetics Summer 
Institute) and WBGI (Web-
based Genetic Institute) 
Genetics: 
 Educational 
http://www.cincinnatichildrens.org/ed/clinicalgpnf/default.htm Medical school course 
competencies, skills, knowledge, 
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Information and behaviors which should be 
covered in genetics 
Kansas Genetics 
Education Center 
http://www.kumc.edu/ gec/ An ever-growing list of available 
resources, lesson plans, etc. 
National Cancer 
Institute’s 
CancerNet 
http://www.cancer.gov/ cancerinfo/prevention genetics-causes Authoritative information about 
cancer genetics 
National 
Coalition for 
Health 
Professional 
Education in 
Genetics 
(NCHPEG) 
http://www.kumc.edu/gec/ Core competencies in genetics 
and reviews of education 
programs . . . Descriptions of 
available instructional resources, 
courses, institutes . . . All have 
been submitted by developers 
and some have accompanying 
peer reviews 
Physician’s 
Database Query 
(PDQ®) Cancer 
Information 
Summaries 
http://www.cancer.gov/ cancerinfo/pdq/genetics PDQ® cancer information 
summaries in genetics 
Practice-Based 
Genetics 
Curricula for 
Nurse Educators 
http://www.fbr.org/ publications/pub_curic. html Bound instructional modules 
with accompanying CD or 
PowerPoint presentations 
(sample chapter available 
online) 
Six Weeks to 
Genomic 
Awareness 
http://www.cdc.gov/ genomics/training/ sixwks.htm Webcast of 12 segments of 
genomic topics for public health 
professionals 
 
Retrieved from Health Professional Practice and Education, pg 63-65.  American Nurses 
Association.  (2009).  The essentials of genetic and genomic nursing:  competencies, 
curricula guidelines, and outcome indicators, 2nd Ed. [PDF file].  Retrieved from 
https://www.genome.gov/pages/careers/healthprofessionaleducation/geneticscompetency.
pdf 
 
 
